Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed ...

California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.

Weight loss drugs like Wegovy, Ozempic, and Mounjaro show transformative effects in obesity, improving heart health and ...

He prefers Mounjaro over Ozempic, another popular GLP-1 inhibitor, due to its fewer side effects and increased effectiveness.

Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...

Musk, who has openly expressed his dislike for exercise, previously revealed in 2022 that he used Wegovy, another GLP-1 ...

Elon Musk took to X on Wednesday to revel in the Christmas spirit. He also reportedly credited Mounjaro for his weight loss.

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...